pH-dependent antigen-binding antibodies as a novel therapeutic modality

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Conventional monoclonal antibodies exhibit limitations in therapeutic applications due to single-instance antigen binding, leading to clearance or accumulation issues.
• Antigen-mediated antibody clearance (membrane-bound antigens) and antibody-mediated antigen accumulation (soluble antigens) are significant challenges in antibody-based therapies.
• The development of novel antibody formats is crucial for overcoming these limitations and enhancing therapeutic efficacy.

Approach:

• pH-dependent antibodies are engineered to bind antigens at neutral plasma pH and dissociate at acidic endosomal pH.
• Fc engineering can further enhance pH-dependent antibodies, particularly those targeting soluble antigens, by improving Fc receptor binding.
• Various methods, including histidine-based engineering and library approaches, are employed to generate these specialized antibodies.

Key Points:

• pH-dependent binding overcomes limitations of conventional antibodies by enabling controlled antigen interaction.
• This approach mitigates antigen-mediated antibody clearance and antibody-mediated antigen accumulation.
• Fc engineering offers a strategy to optimize the performance of pH-dependent antibodies against soluble antigens.

Conclusions:

• pH-dependent binding antibodies represent a promising novel therapeutic modality with improved pharmacokinetic profiles.
• The development of these antibodies involves diverse engineering strategies and offers significant advantages over conventional formats.
• Further research into the features, approaches, and challenges is essential for advancing this therapeutic strategy.